SCHEMBL26089966

SCHEMBL26089966

Cc1cc(OC(N)=O)cc(C)c1C#N

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
TSHR P16473 1/20 0.41
UPP1 Q16831 1/20 0.40
KDM4E B2RXH2 8/20 0.38
ALDH1A1 P00352 4/20 0.37
TDP1 Q9NUW8 2/20 0.37
HPGD P15428 2/20 0.36
RECQL P46063 3/20 0.36
LMNA P02545 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
SCN9A Q15858 1/20 0.35
MAPT P10636 1/20 0.34
ALOX15 P16050 1/20 0.34
HSD17B10 Q99714 1/20 0.34
APOBEC3G Q9HC16 1/20 0.34
HAVCR2 Q8TDQ0 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29177255 0.89 KMT2A (0.37) MEN1KMT2ATSHRUPP1KDM4E
SCHEMBL29177294 0.81 MEN1 (0.39) MEN1KMT2ATSHRKDM4EALDH1A1
SCHEMBL9721680 0.78 KMT2A (0.50) MEN1KMT2ATSHRALDH1A1TDP1
SCHEMBL28823338 0.76 KMT2A (0.48) MEN1KMT2ATSHRKDM4EALDH1A1
SCHEMBL26090155 0.75 MGLL (0.45) MEN1KMT2AMAPT
SCHEMBL28378653 0.75 RECQL (0.44) MEN1KMT2ATSHRUPP1KDM4E
SCHEMBL20152482 0.75 KMT2A (0.51) MEN1KMT2AKDM4EALDH1A1TDP1
SCHEMBL29177225 0.75 KMT2A (0.47) MEN1KMT2ATSHRKDM4EALDH1A1
SCHEMBL17664154 0.75 TSHR (0.44) MEN1KMT2ATSHRUPP1KDM4E
SCHEMBL29177218 0.74 KMT2A (0.47) MEN1KMT2ATSHRKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117242060-A Isoindolinone compounds 蒙特罗萨医疗公司 2023-12-15 CN disclosed
WO-2023069708-A1 COMPOUNDS THAT MEDIATE PROTEIN DEGRADATION AND USES THEREOF MONTE ROSA THERAPEUTICS, INC. (US) 2023-04-27 WO disclosed